Michela Servadio1, Valeria Belleudi1, Marco Finocchietti1
1Dipartimento di epidemiologia, Servizio sanitario regionale del Lazio, Asl Roma 1.
This study estimates 74 diffuse large B-cell lymphoma (DLBCL) patients in Lazio are eligible for CAR-T therapy in 2024. Real-world data analysis helps define target populations for innovative immunotherapies.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: